register now
conference
get brochure
sponsors
add event to diary
email this to...
contact us
The ViE Awards
 
Nominations are closed!
A ViE Award is more than just a trophy, it is recognition of the vaccine industry’s achievements and contributions to the forward development of the immunotherapy industry.
 
  • Best contract research organisation
    The award will be based on facilities, services and customer relations
  • Life time achievement award
    To honour the efforts of an exceptional person in the vaccine field.
  • Best new vaccine – in development
    This award is split into two categories – vaccines in early stage development and vaccines in clinical trials

› View full category list

› The ViE Awards Website

Book a table for the big night
  Like actors and studio bosses who recognise how winning an Oscar can multiply their market value, boardrooms across the globe are seeing similar effects with industry awards.

› Book a table

 

Our sponsors

GE Healthcare provides transformational medical technologies that are shaping a new age of patient care.  GE Healthcare’s expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, disease research, drug discovery and biopharmaceutical manufacturing technologies is dedicated to detecting disease earlier and helping physicians tailor treatment for individual patients.  GE Healthcare offers a broad range of products and services to improve productivity in healthcare and enable healthcare providers to better diagnose, treat and manage patients with conditions such as cancer, neurological and cardiovascular diseases. 
 
GE Healthcare is a supplier to the stem cell therapy and blood banking markets. We provide a generic automated and integrated processing and storage solution to the fast growing cord blood market as well as reagents for research and cell therapy clinical R&D. Our leading brands include Ficoll-Paque™ PREMIUM, AXP™ AutoXpress Platform and BioArchive® System. To find out more visit www.gehealthcare.com/cellprep

 

Pall Corporation is the global leader in the rapidly growing field of filtration, separations and purification, especially in the biopharmaceutical industry for the production of biotech and biopharmaceutical products.

Pall's Life Sciences Group is fully integrated to offer product lines that start in the laboratory with drug discovery, gene manipulation and proteomics applications, and extend into drug development, process scale up, through to full drug manufacturing production and patient delivery. Pall's extensive expertise helps its customers throughout the drug approval regulatory process, and its filtration systems and validation services offer drug manufacturers the quickest and surest path through the regulatory process and onto the market. As Mr Jerold M. Martin, Senior Vice President and Global Technical Director for Pall Life Sciences' BioPharmaceuticals division said, "Pall Corporation is committed to developing the most advanced, cost-effective virus filtration products that maximize customers' opportunity for success."

 

Covance — one of the world's largest and most comprehensive drug development services companies — has the people, global resources and problem-solving culture to respond to pharmaceutical and biotechnology clients' toughest drug development challenges.

We provide a portfolio of preclinical and clinical development and commercial service offerings — delivered through industry-leading nonclinical testing services, the world's largest central laboratory network, and a global team of clinical trial professionals and cardiac safety experts.

 
As the worldwide leader in clinical research, Quintiles has in-depth expertise in vaccines and an exceptional track record:  since 2000, we have conducted 70 vaccine studies involving more than 144,000 patients in 56 countries.  Our experience spans Phases I-IV studies in the prevention of influenza, HIV, hepatitis,  pneumococcal, pertussis, RSV,  anthrax, plague, smallpox, melanoma, and many other vaccine areas.  Worldwide, you can count on Quintiles to deliver the results you need.  Visit us at www.quintiles.com.
 
Synco BioPartners is one of Europes leading Contract Manufacturing Organizations. Focusing exclusively on Biopharmaceuticals and Vaccines, Synco offers a complete range of manufacturing services including fermentation development, downstream process development, assay development and CGMP manufacture for Phase I-III clinical trials and market supply. Synco also offers a filling and lyophilization service, again to CGMP. Synco has an extensive track record of succesful manufacturing project, and is currently engaged in the manufacture of APIs for clinical trials and for European market supply.
 

It is Crucell’s goal to improve healthcare throughout the world by fighting infectious diseases. Crucell does this by discovering, researching and developing technologies, vaccines and antibodies, using its own fully integrated infrastructure for in-house development, production and marketing and, where useful or necessary, by establishing partnerships with other companies and organizations.  Headquartered in Leiden, The Netherlands, Crucell currently employs about 1100 people and has subsidiaries in Switzerland, Spain, Sweden, Italy and Korea. Crucell N.V. is listed on Euronext and NASDAQ (CRXL) and the SWX Swiss Exchange (CRX). At Crucell, we’re bringing innovation to global health.

BD (Becton, Dickinson and Company) is a global medical technology company that is focused on improving drug therapy, enhancing the diagnosis of infectious diseases and advancing drug discovery. BD manufactures and sells medical supplies, devices, laboratory instruments, antibodies, reagents and diagnostic products through its three segments: BD Medical, BD Diagnostics and BD Biosciences. It serves healthcare institutions, life science researchers, clinical laboratories, industry and the general public.  www.bd.com

www.ovagen.com

 

Exhibitor and seat-drop sponsor

Accelovance is a vaccine-focused patient delivery organization.   We have a database of 50,000+ subjects including healthy and controlled normals that is managed by our patient recruitment division.  We own nine (9) research dedicated clinical sites, in which we operate a high throughput process for performing vaccine studies. Our full service vaccine experienced CRO is offered to meet Sponsors’ needs with value enhancing features that include; exceptional quality standards, rapid start up, focused qualified team, proven performance in meeting time lines at cost effective rates. www.accelovance.com

 

 

Contact Neil Darkes to tailor your sponsorship package on +44 (0) 207 092 1240 or neil.darkes@terrapinn.com

 
event sponsors
Gold:

conference details

World Vaccine Congress Washington 2008

8th annual event!Your best chance to learn about the business of making vaccines and to meet people that can revolutionise your business.

Conference:
Pre-congress briefing
21 April 2008 8am - 5:30pm
Congress day one
22 April 2008 8am - 5:30pm
The ViE Awards
22 April 2008  7.30pm - 1am
Congress day two
23 April 2008 8am - 5:30pm
Post-congress briefing
24 April 2008 8am - 5:30pm

 Add this to my calendar

 

sponsorship opportunities

 Grow your business - sponsorship really works

  • Get cost effective marketing exposure and branding to your target audience, culminating in face-to-face meetings with your top prospects
  • Position yourself as an industry leader
  • Increase your brand recognition
  • Create new partnerships and alliances
  • Showcase products and services to a targeted audience of decision-makers
 

Target you market!For sponsorship opportunities please contact
Neil Darkes